Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
A ALIMENTARY TRACT AND METABOLISM
A07 ANTIDIARRHEALS, INTESTINAL ANTIINFLAMMATORY/ANTIINFECTIVE AGENTS
A07A INTESTINAL ANTIINFECTIVES
A07AA Antibiotics
A07AA12 Fidaxomicin
D09394 Fidaxomicin (JAN/USAN) <JP/US>
USP drug classification [BR:br08302]
Antibacterials
Macrolides
Fidaxomicin
D09394 Fidaxomicin (JAN/USAN)
Therapeutic category of drugs in Japan [BR:br08301]
6 Agents against pathologic organisms and parasites
61 Antibiotics
611 Acting mainly on gram-positive bacteria
6119 Others
D09394 Fidaxomicin (JAN/USAN)
Drug groups [BR:br08330]
Antibacterial
DG01551 Macrolide antibiotic
D09394 Fidaxomicin
Metabolizing enzyme inhibitor
DG01643 CYP2C9 inhibitor
D09394 Fidaxomicin
DG01933 CYP2C19 inhibitor
D09394 Fidaxomicin
DG02852 CYP3A/CYP3A4 inhibitor
DG01522 CYP3A4 inhibitor
D09394 Fidaxomicin
Transporter inhibitor
DG01622 ABCB1 inhibitor
D09394 Fidaxomicin
Drug classes [BR:br08332]
Antibacterial
DG01551 Macrolide antibiotic
D09394 Fidaxomicin
Antimicrobials [BR:br08307]
Antibacterials
Protein biosynthesis inhibitor
Aminoglycoside
D09394 Fidaxomicin (JAN/USAN) <JP/US>
Antimicrobials abbreviations [BR:br08327]
Antibacterials
Protein biosynthesis inhibitor
Aminoglycoside
D09394 Fidaxomicin (JAN/USAN)
New drug approvals in the USA [br08319.html]
New molecular entities and new therapeutic biological products
D09394
New drug approvals in Europe [br08329.html]
European public assessment reports (EPAR) authorised medicine
D09394
New drug approvals in Japan [br08318.html]
Drugs with new active ingredients
D09394
New drug approvals in the USA, Europe and Japan [br08328.html]
Approval dates by FDA, EMA and PMDA
D09394
Drug metabolizing enzymes and transporters [br08309.html]
Drug metabolizing enzymes
D09394
Drug transporters
D09394